Slide 1

Progression-free survival of 1,059 early PET–negative patients who were

treated per the initial protocol

progression-free survival of the (A) favorable (F) groups of patients randomly assigned to ABVD

+ involved-node radiotherapy (INRT; n = 227) or ABVD only (n = 238) and of the (B) unfavorable

(U) groups randomly assigned to ABVD + INRT (n = 292) or ABVD only (n = 302).

Published in: Marc P.E. André; et al ;

JCO

2017,

35, 1786-1794

Favourable

Unfavourable